Systematic review and meta-analysis on management of acute urinary retention

Yoon, Peter; Chalasani, Venu; Woo, Henry H.

doi:10.1038/pcan.2015.15

Cited by 37 publications

(24 citation statements)

References 55 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Management of UR secondary to BPO (UR/BPO) varies widely. Relevant systematic reviews (SRs) are scarce [19][20][21]. The European Association of Urology (EAU) Nonneurogenic Male Lower Urinary Tract Symptoms (LUTS) Guidelines Panel acknowledges the current lack of high certainty of evidence (CoE) and the growing scientific base, and cites the need to understand more about management options.…”

mentioning

confidence: 99%

Management of urinary retention in patients with benign prostatic obstruction: A systematic review and meta-analysis

Karavitakis¹,

Kyriazis²,

Omar³

et al. 2019

European Urology Supplements

View full text Add to dashboard Cite

E U R O P E A N U R O L O G Y X X X ( 2 0 1 8 ) X X X -X X X a v a i l a b l e a t w w w . s c i e n c e d i r e c t . c o m j o u r n a l h o m e p a g e : w w w . e u r o p e a n u r o l o g y . c o m AbstractContext: Practice patterns for the management of urinary retention (UR) secondary to benign prostatic obstruction (BPO; UR/BPO) vary widely and remain unstandardized. Objective: To review the evidence for managing patients with UR/BPO with pharmacological and nonpharmacological treatments included in the European Association of Urology guidelines on non-neurogenic male lower urinary tract symptoms. Evidence acquisition: Search was conducted up to April 22, 2018, using CENTRAL, MEDLINE, Embase, ClinicalTrials.gov, and World Health Organization International Clinical Trials Registry Platform. This systematic review included randomized controlled trials (RCTs) and prospective comparative studies. Methods as detailed in the Cochrane handbook were followed. Certainty of evidence (CoE) was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. Evidence synthesis: Literature search identified 2074 citations. Twenty-one studies were included (qualitative synthesis). The evidence for managing patients with UR/ BPO with pharmacological or nonpharmacological treatments is limited. CoE for most outcomes was low/very low. Only a1-blockers (alfuzosin and tamsulosin) have been evaluated in more than one RCT. Pooled results indicated that a1-blockers provided significantly higher rates of successful trial without catheter compared with placebo [alfuzosin: 322/540 (60%) vs 156/400 (39%) (odds ratio {OR} 2.28, 95% confidence interval {CI} 1.55 to 3.36; participants = 940; studies = 7; I 2 = 41%; low CoE); tamsulosin: 75/158 (47%) vs 40/139 (29%) (OR 2.40, 95% CI 1.29 to 4.45; participants = 297; studies = 3; I 2 = 30%; low CoE)] with rare adverse events. Similar rates were achieved with tamsulosin or alfuzosin [51/87 (59%) vs 45/84 (54%) (OR 1.28, 95% CI 0.68 to 2.41;

show abstract

mentioning

confidence: 99%

Management of urinary retention in patients with benign prostatic obstruction: A systematic review and meta-analysis

Karavitakis¹,

Kyriazis²,

Omar³

et al. 2019

European Urology Supplements

View full text Add to dashboard Cite

show abstract

“…There is controversy surrounding the length of catheterisation time and its relationship with successful IDC removal. Five studies reviewed by Yoon et al (2015) revealed no consistency regarding timing and success. It was however noted that having an indwelling urinary catheter for greater than 3 days was affiliated with increased complication such as infection (Yoon et al, 2015).…”

Section: Discussionmentioning

confidence: 99%

“…Five studies reviewed by Yoon et al (2015) revealed no consistency regarding timing and success. It was however noted that having an indwelling urinary catheter for greater than 3 days was affiliated with increased complication such as infection (Yoon et al, 2015). The rate of hospital acquired UTIs reported in our study were the same (12%) for both successful and unsuccessful IDC removals (p=0.99).…”

Section: Discussionmentioning

confidence: 99%

“…Urinary retention is defined as the inability to voluntarily void urine (Selius & Subedi, 2008). It is acknowledged that urinary retention can have a debilitating impact on both the patient's quality of life as well as causing increased cost within the health system (Yoon, V, & Woo, 2015). Urinary retention is a common problem following indwelling urinary catheter removal and is estimated to potentially occur from 7 to 48 hours post removal (Griffiths, Fernandez, & Murie, 2004).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Factors associated with the successful removal of indwelling urinary catheters post-operatively in the fragility hip fracture patient

Lynch

Bell

Long

et al. 2016

International Journal of Orthopaedic and Trauma Nursing

View full text Add to dashboard Cite

“…4 Acute urinary retention can be broadly classified as spontaneous AUR (sAUR), which mainly occurs secondary to the natural history of BPH, and precipitated AUR, which occurs in response to a surgical procedure involving general or loco-regional anesthesia, bladder over-distension, urinary tract infection, or medications with sympathomimetic or anticholinergic effects. 4,5 Age, severe LUTS, low maximum urine flow rate (Qmax), high post-void residual urine, huge prostate, and high serum PSA levels have been proposed as significant risk factors for sAUR. 3,6 Several studies have addressed the relationship between climatic parameters and BPH/LUTS symptoms.…”

Section: Introductionmentioning

confidence: 99%